A novel small-molecule inhibitor of HIV-1 entry

BACKGROUND: Antiretroviral therapy has transformed HIV-1 infection into a managed condition with near-normal life expectancy. However, a significant number of patients remain with limited therapeutic options due to HIV-1 resistance, side effects, or drug costs. Further, it is likely that current dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Heredia, Alonso, Latinovic, Olga S, Barbault, Florent, de Leeuw, Erik PH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598220/
https://www.ncbi.nlm.nih.gov/pubmed/26491257
http://dx.doi.org/10.2147/DDDT.S89338

Ejemplares similares

Ejemplares similares